HQL
Tekla Life Sciences Investors
NYSE · Financial Services · Asset Management · US
$20.64
−0.34%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- 0.00x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.00x
Liquidity & coverage
- Current ratio
- 2.58x
- Quick ratio
- 2.58x
- Cash ratio
- 1.03x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $1.3M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- $2.24
- Dividend yield
- 10.9%
- Dividend growth 1y
- -2.2%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026